Dual roles of dendritic cells in liver transplantation immunity and their translational progress
Chinese Bulletin of Life Sciences · 01.04.2026 · 38 (4) · 721-735
DOI: 10.3724/cbls.2026080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Bulletin of Life Sciences, online erschienen am 01.06.2026. Verfasst von Li DU und 3 weiteren Autor:innen. Die Arbeit nennt 109 Literaturangaben.
Abstract (Originalsprache)
Liver transplantation (LT) remains the definitive treatment for end-stage liver disease; however, its long-term success is limited by the lifelong dependence on immunosuppressive therapy and its associated complications. Dendritic cells (DCs), as key orchestrators bridging innate and adaptive immunity, play a dual and paradoxical role in LT by simultaneously driving allograft rejection and promoting immune tolerance. This review provides a comprehensive synthesis of DCs immunobiology in LT, with a focus on their functional heterogeneity, spatial distribution, and dynamic fate determination. We first summarize the three principal DCs-mediated allorecognition pathways—direct, indirect, and semi-direct—and highlight their temporal interplay across different transplantation stages. Notably, the semi-direct pathway, characterized by “cross-dressing” of recipient DCs with intact donor MHC complexes, emerges as a critical mechanism for immune regulation and tolerance induction within the unique hepatic microenvironment. A central concept of this review is that immunometabolic reprogramming governs DCs functional fate. Immunogenic DCs predominantly rely on glycolysis to support rapid activation and pro-inflammatory responses, whereas tolerogenic DCs (tolDCs) preferentially utilize oxidative phosphorylation and fatty acid oxidation to maintain their regulatory phenotype. This metabolic dichotomy functions as a molecular switch that integrates environmental cues—including ischemia–reperfusion injury, damage-associated molecular patterns, and immunosuppressive signals—thereby shaping DCs-mediated immune outcomes. From a translational perspective, we discuss emerging DCs-targeted therapeutic strategies, including ex vivo–generated tolDCs therapy, in vivo DCs reprogramming via nanodelivery systems, and cell-free approaches such as extracellular vesicles. Early clinical studies indicate that tolDCs infusion is safe and capable of reshaping host immunity by promoting regulatory T cell expansion while suppressing effector CD8+ T cells and natural killer cells. However, key challenges remain, including phenotypic stability, manufacturing standardization, and potential interactions with conventional immunosuppressive regimens. Finally, we propose that integrating single-cell and spatial transcriptomics with DCs-based biomarkers may enable the identification of “tolerance signatures” for real-time immune monitoring and personalized immunosuppression minimization. Collectively, targeting DCs biology represents a promising strategy to achieve antigen-specific immune tolerance and improve long-term outcomes in liver transplantation.
Zitieren
APA
DU, L., LIU, F., HE, J., & WANG, W. (2026). Dual roles of dendritic cells in liver transplantation immunity and their translational progress. Chinese Bulletin of Life Sciences, 38(4), 721-735. https://doi.org/10.3724/cbls.2026080
Vancouver
DU L, LIU F, HE J, WANG W. Dual roles of dendritic cells in liver transplantation immunity and their translational progress. Chinese Bulletin of Life Sciences. 2026;38(4):721-735. doi:10.3724/cbls.2026080
BibTeX
@article{DU2026,
author = {DU, Li and LIU, Fang-Fang and HE, Jun-Ming and WANG, Wen-Ya},
title = {Dual roles of dendritic cells in liver transplantation immunity and their translational progress},
journal = {Chinese Bulletin of Life Sciences},
year = {2026},
volume = {38},
number = {4},
pages = {721--735},
doi = {10.3724/cbls.2026080}
}
EUVIMED